BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37307777)

  • 1. Injectable cold atmospheric plasma-activated immunotherapeutic hydrogel for enhanced cancer treatment.
    Fang T; Cao X; Shen B; Chen Z; Chen G
    Biomaterials; 2023 Sep; 300():122189. PubMed ID: 37307777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trehalose enhanced cold atmospheric plasma-mediated cancer treatment.
    Cao X; Fang T; Chen M; Ning T; Li J; Siegel PM; Park M; Chen Z; Chen G
    Biomaterials; 2024 Sep; 309():122582. PubMed ID: 38678699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
    Han X; Li H; Zhou D; Chen Z; Gu Z
    Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal cold atmospheric plasma-mediated immune checkpoint blockade therapy.
    Chen G; Chen Z; Wen D; Wang Z; Li H; Zeng Y; Dotti G; Wirz RE; Gu Z
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3687-3692. PubMed ID: 32029590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable Micelle-Incorporated Hydrogels for the Localized Chemo-Immunotherapy of Breast Tumors.
    Qin X; He L; Feng C; Fan D; Liang W; Wang Q; Fang J
    ACS Appl Mater Interfaces; 2021 Oct; 13(39):46270-46281. PubMed ID: 34550685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer.
    Wu W; Xu M; Qiao B; Huang T; Guo H; Zhang N; Zhou L; Li M; Tan Y; Zhang M; Xie X; Shuai X; Zhang C
    Acta Biomater; 2023 Mar; 158():547-559. PubMed ID: 36539109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable Supramolecular Hydrogel for Locoregional Immune Checkpoint Blockade and Enhanced Cancer Chemo-Immunotherapy.
    Liu M; Cao Z; Zhang R; Chen Y; Yang X
    ACS Appl Mater Interfaces; 2021 Jul; 13(29):33874-33884. PubMed ID: 34275267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.
    Song H; Yang P; Huang P; Zhang C; Kong D; Wang W
    Theranostics; 2019; 9(8):2299-2314. PubMed ID: 31149045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
    Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
    Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-Dependent Effects in Plasma Oncotherapy: Critical In Vivo Immune Responses Missed by In Vitro Studies.
    He Y; Gong F; Jin T; Liu Q; Fang H; Chen Y; Wang G; Chu PK; Wu Z; Ostrikov KK
    Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable Anti-inflammatory Nanofiber Hydrogel to Achieve Systemic Immunotherapy Post Local Administration.
    Chen M; Tan Y; Dong Z; Lu J; Han X; Jin Q; Zhu W; Shen J; Cheng L; Liu Z; Chen Q
    Nano Lett; 2020 Sep; 20(9):6763-6773. PubMed ID: 32787149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cold atmospheric plasma-induced oxidative stress and ensuing immunological response - a Neo-Vista in immunotherapy.
    P R S; K S; S Y
    Free Radic Res; 2022; 56(7-8):498-510. PubMed ID: 36282274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current State of Cold Atmospheric Plasma and Cancer-Immunity Cycle: Therapeutic Relevance and Overcoming Clinical Limitations Using Hydrogels.
    Živanić M; Espona-Noguera A; Lin A; Canal C
    Adv Sci (Weinh); 2023 Mar; 10(8):e2205803. PubMed ID: 36670068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External cold atmospheric plasma-responsive on-site hydrogel for remodeling tumor immune microenvironment.
    Byun J; Wu Y; Lee J; Kim JS; Shim G; Oh YK
    Biomaterials; 2023 Aug; 299():122162. PubMed ID: 37257401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade.
    Yu S; Wang C; Yu J; Wang J; Lu Y; Zhang Y; Zhang X; Hu Q; Sun W; He C; Chen X; Gu Z
    Adv Mater; 2018 Jul; 30(28):e1801527. PubMed ID: 29786888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
    Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
    Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell-based vaccines for ameliorating cancer chemoimmunotherapy.
    Su L; Hao Y; Li R; Pan W; Ma X; Weng J; Min Y
    Acta Biomater; 2022 Dec; 154():401-411. PubMed ID: 36241013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cold atmospheric plasma sensitizes head and neck cancer to chemotherapy and immune checkpoint blockade therapy.
    Wang Y; Mang X; Li D; Wang Z; Chen Y; Cai Z; Tan F
    Redox Biol; 2024 Feb; 69():102991. PubMed ID: 38103343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cold Physical Plasma in Cancer Therapy: Mechanisms, Signaling, and Immunity.
    Faramarzi F; Zafari P; Alimohammadi M; Moonesi M; Rafiei A; Bekeschus S
    Oxid Med Cell Longev; 2021; 2021():9916796. PubMed ID: 35284036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.